The maximum dose of stabilized, cross-linked hyaluronic acid of non-animal origin in the optimal volume for effective viscosupplementation in an injectable medical device class III.

• Thanks to its molecular weight of 2.3 MDa, DIART ONE exhibits viscosupplementation properties that closely resemble those of the synovial fluid in a healthy individual;

• The special technology of “soft cross-linking” of hyauronic acid allows to achieve the cross-linking ratio of 0.18%, wich minimizes the adverse effects of additional chemical compounds used to stabilize hyauloronic acid;

• Single injection for the treatment course

Strength:     

DIART ONE 20 mg/ml in 2 ml syringe 40 mg stabilized cross-linked hyauronic acid

DIART ONE 20 mg/ml in 4 ml syringe 80 mg stabilized cross-linked hyauronic acid

DIART ONE 30 mg/ml in 3 ml syringe 90 mg stabilized cross-linked hyauronic acid